肥厚型心肌病的临床表现及其对治疗的意义。 - Suppr

Suppr

超能文献

Clinical presentations of hypertrophic cardiomyopathy and implications for therapy.

作者信息

Díez-López Carles, Salazar-Mendiguchía Joel

机构信息

Advanced Heart Failure and Heart Transplant Unit. Heart Institute. Bellvitge University Hospital. Barcelona, Spain.

Health in Code. Cardiovascular Genetics Department. A Coruña, Spain.

出版信息

Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):19. doi: 10.21542/gcsp.2018.19.

DOI:10.21542/gcsp.2018.19

PMID:30393631

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6209433/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7862/6209433/a8d8aec1cf04/gcsp-2018-3-e201819-g001.jpg

相似文献

Clinical presentations of hypertrophic cardiomyopathy and implications for therapy.

Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):19. doi: 10.21542/gcsp.2018.19.

Exercise in patients with hypertrophic cardiomyopathy: A review of current evidence, national guideline recommendations and a proposal for a new direction to fitness.

J Sci Med Sport. 2017 Apr;20(4):333-338. doi: 10.1016/j.jsams.2016.09.007. Epub 2016 Sep 20.

The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.

J Am Coll Cardiol. 2009 Jul 14;54(3):191-200. doi: 10.1016/j.jacc.2008.11.069.

Clinical and echocardiographic features of hypertrophic cardiomyopathy in the elderly.

Am J Geriatr Cardiol. 2001 Jan-Feb;10(1):11-7; quiz 17-9. doi: 10.1111/j.1076-7460.2001.90850.x.

Stress Cardiomyopathy in a Patient with Hypertrophic Cardiomyopathy: Case Presentation and Review of the Literature.

Rev Cardiovasc Med. 2018 Jun 30;19(2):65-68. doi: 10.31083/j.rcm.2018.02.893.

Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications.

Int J Cardiol. 2004 Dec;97(3):479-84. doi: 10.1016/j.ijcard.2003.11.014.

Difficult cases in heart failure. Percutaneous transluminal septal myocardial ablation in the management of hypertrophic obstructive cardiomyopathy.

Congest Heart Fail. 2003 Nov-Dec;9(6):343-6. doi: 10.1111/j.1527-5299.2003.02746.x.

Age-dependent heterogeneity of familiar hypertrophic cardiomyopathy phenotype: a role of cardiovascular magnetic resonance.

Medicina (Kaunas). 2013;49(9):422-5.

Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.

Expert Rev Mol Diagn. 2004 Jan;4(1):99-113. doi: 10.1586/14737159.4.1.99.

Tissue Doppler imaging and long axis left ventricular function: hypertrophic cardiomyopathy versus athlete's heart.

Rev Port Cardiol. 2002 Jun;21(6):679-707.

引用本文的文献

Hyperpolarized-MRI in Hypertrophic Cardiomyopathy: A Narrative Review.

Clin Med Insights Cardiol. 2025 Aug 29;19:11795468251369234. doi: 10.1177/11795468251369234. eCollection 2025.

The Relationship Between BigET-1 and Cardiac Remodeling in Patients with Hypertrophic Obstructive Cardiomyopathy.

Mol Biotechnol. 2024 Nov 19. doi: 10.1007/s12033-024-01308-1.

Assessment of papillary muscle free strain in hypertrophic cardiomyopathy and hypertension-induced left ventricular hypertrophy.

Cardiovasc J Afr. 2023;34(3):169-174. doi: 10.5830/CVJA-2022-070. Epub 2023 Feb 27.

Hypertrophic Cardiomyopathy in Saudi Arabia: A Systematic Review of the Epidemiological, Clinical, and Imaging Features.

Curr Cardiol Rev. 2023;19(2):e250822208003. doi: 10.2174/1573403X18666220825153725.

Hemoptysis as a rare presenting symptom of hypertrophic obstructive cardiomyopathy.

Indian J Thorac Cardiovasc Surg. 2020 Nov;36(6):653-656. doi: 10.1007/s12055-020-00985-2. Epub 2020 Jul 25.

The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers.

Int J Mol Sci. 2020 Sep 12;21(18):6682. doi: 10.3390/ijms21186682.

本文引用的文献

Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.

Circ Genom Precis Med. 2018 Apr;11(4):e001896. doi: 10.1161/CIRCGEN.117.001896.

Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study.

Circ Heart Fail. 2018 Jan;11(1):e004124. doi: 10.1161/CIRCHEARTFAILURE.117.004124.

Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.

Europace. 2018 Jan 1;20(1):82-88. doi: 10.1093/europace/euw327.

Women with hypertrophic cardiomyopathy have worse survival.

Eur Heart J. 2017 Dec 7;38(46):3434-3440. doi: 10.1093/eurheartj/ehx527.

Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience.

Ann Cardiothorac Surg. 2017 Jul;6(4):353-363. doi: 10.21037/acs.2017.07.07.

Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis.

Sci Rep. 2017 Sep 20;7(1):11957. doi: 10.1038/s41598-017-12289-4.

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.

Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.

Circ Res. 2017 Sep 15;121(7):771-783. doi: 10.1161/CIRCRESAHA.116.309348.

Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Arrhythm Electrophysiol Rev. 2017 Jun;6(2):63-68. doi: 10.15420/aer.2017.4.2.

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Int J Cardiol. 2017 Dec 1;248:232-238. doi: 10.1016/j.ijcard.2017.08.010. Epub 2017 Aug 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验